4.9
Longoedeem II: Pathofysiologie
Longoedeem is de ophoping van vocht in de interstitiële en alveolaire ruimten van de longen, waardoor de gaswisseling en zuurstofafgifte worden belemm…
Cardiogenic pulmonary edema typically begins with left ventricular dysfunction, as seen in heart failure.
This raises hydrostatic pressure in the pulmonary capillaries, causing net fluid movement from the capillary into the interstitial space and flooding the alveoli.
On the other hand, in noncardiogenic edema, the primary mechanism is increased capillary permeability, often triggered by the occurrence of acute respiratory distress syndrome or toxic inhalation.
Protein-rich fluid leaks into the alveoli, drawing in additional water osmotically.
In both cases, alveolar fluid disrupts surfactant, increases surface tension, and reduces lung compliance, making breathing more difficult. Gas exchange declines due to increased diffusion distance and ventilation–perfusion mismatch.
If left untreated, pulmonary edema can progress to respiratory failure, marked by severe dyspnea, or shortness of breath; hypoxemia, or low blood oxygen; and hypercapnia, or elevated carbon dioxide levels.
View the full transcript and gain access to JoVE Core videos
Q1: What causes cardiogenic pulmonary edema?
Cardiogenic pulmonary edema results from left ventricular dysfunction, commonly seen in heart failure, myocardial infarction, or valvular disease. This dysfunction raises hydrostatic pressure in pulmonary capillaries, disrupting the balance between hydrostatic and oncotic forces. Fluid moves from capillaries into interstitial and alveolar spaces, impairing gas exchange and causing hypoxemia and dyspnea.
Q2: How does noncardiogenic pulmonary edema develop differently from cardiogenic edema?
Noncardiogenic edema occurs with normal hydrostatic pressure but increased capillary permeability due to injury or inflammation of the alveolar-capillary membrane. Conditions like acute respiratory distress syndrome or toxic inhalation damage endothelial barriers, allowing protein-rich fluid to leak into alveoli. This high-protein fluid draws in additional water osmotically, worsening edema without cardiac dysfunction.
Q3: How does pulmonary edema affect lung compliance and breathing?
Fluid accumulation in alveoli disrupts surfactant, increases surface tension, and reduces lung compliance, making alveolar expansion difficult. Increased diffusion distance and ventilation-perfusion mismatch further impair gas exchange. These changes force the respiratory muscles to work harder, increasing breathing effort and contributing to dyspnea and reduced oxygenation.
Q4: What are the severe complications of untreated pulmonary edema?
Untreated pulmonary edema can progress to acute respiratory failure, characterized by severe dyspnea, hypoxemia (low blood oxygen), and hypercapnia (elevated carbon dioxide). Fluid-filled alveoli cannot participate in gas exchange, leading to refractory hypoxemia. Prompt identification of the underlying cause is critical, as cardiogenic and noncardiogenic edema require distinct treatment strategies to restore adequate gas exchange.
Q5: Why does protein-rich fluid worsen noncardiogenic pulmonary edema?
In noncardiogenic edema, damaged alveolar-capillary membranes allow protein-rich fluid to leak into alveoli. The high protein concentration creates an osmotic gradient that draws additional water into the alveolar space, amplifying fluid accumulation. This mechanism differs from cardiogenic edema, where hydrostatic pressure drives fluid movement without significant protein leakage.
Q6: How does pulmonary edema impair gas exchange?
Fluid-filled alveoli cannot participate in gas exchange, increasing the diffusion distance between blood and air. Ventilation-perfusion mismatch occurs when fluid blocks ventilation to perfused areas. Together, these changes reduce oxygen uptake and carbon dioxide elimination, causing hypoxemia and hypercapnia that characterize respiratory failure if severe.
Q7: Why is distinguishing between cardiogenic and noncardiogenic edema important for treatment?
Cardiogenic and noncardiogenic pulmonary edema require distinct treatment strategies because they result from different pathophysiologic mechanisms. Cardiogenic edema stems from left ventricular dysfunction and elevated hydrostatic pressure, while noncardiogenic edema involves increased capillary permeability. Patients with respiratory complications may also benefit from understanding chronic obstructive pulmonary disease clinical manifestations to recognize overlapping symptoms.